These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28754132)

  • 1. Interactions between glycopyrronium and indacaterol on cholinergic neurotransmission and contractile response in bovine trachealis.
    Baroffio M; Barisione G; Brusasco V
    Respir Res; 2017 Jul; 18(1):145. PubMed ID: 28754132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells.
    Cazzola M; Calzetta L; Puxeddu E; Ora J; Facciolo F; Rogliani P; Matera MG
    Respir Res; 2016 Jun; 17(1):70. PubMed ID: 27296533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of (a Combination of) the Beta
    Maarsingh H; Oldenburger A; Han B; Zuidhof AB; Elzinga CRS; Timens W; Meurs H; Sopi RB; Schmidt M
    Cells; 2021 May; 10(5):. PubMed ID: 34069899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of indacaterol on the LPS-evoked changes in fluid secretion rate and pH in swine tracheal membrane.
    Aritake H; Tamada T; Murakami K; Gamo S; Nara M; Kazama I; Ichinose M; Sugiura H
    Pflugers Arch; 2021 Jun; 473(6):883-896. PubMed ID: 34031755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indacaterol, glycopyrronium, and mometasone: Pharmacological interaction and anti-inflammatory profile in hyperresponsive airways.
    Rogliani P; Ritondo BL; Facciolo F; Matera MG; Nikolaev I; Calzetta L
    Pharmacol Res; 2021 Oct; 172():105801. PubMed ID: 34363950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety of glycopyrrolate: A randomized study in patients with moderate-to-severe COPD (GEM3).
    Mahler DA; Gifford AH; Satti A; Jessop N; Eckert JH; D'Andrea P; Mota F; Banerjee R
    Respir Med; 2016 Jun; 115():39-45. PubMed ID: 27215502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of κ- and μ-opioid agonists on cholinergic neurotransmission and contraction in isolated bovine trachealis.
    Baroffio M; Crimi E; Rehder K; Brusasco V
    Respir Physiol Neurobiol; 2013 Jan; 185(2):281-6. PubMed ID: 23063739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical facilitation of acetylcholine release from parasympathetic nerves innervating guinea-pig trachea by isoprenaline.
    Belvisi MG; Patel HJ; Takahashi T; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1996 Apr; 117(7):1413-20. PubMed ID: 8730733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta 2-adrenoceptor activation augments acetylcholine release from tracheal parasympathetic nerves.
    Zhang XY; Olszewski MA; Robinson NE
    Am J Physiol; 1995 Jun; 268(6 Pt 1):L950-6. PubMed ID: 7611436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study.
    Vincken W; Aumann J; Chen H; Henley M; McBryan D; Goyal P
    Int J Chron Obstruct Pulmon Dis; 2014; 9():215-28. PubMed ID: 24596459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of enantiomers of beta 2-agonists on ACh release and smooth muscle contraction in the trachea.
    Zhang XY; Zhu FX; Olszewski MA; Robinson NE
    Am J Physiol; 1998 Jan; 274(1):L32-8. PubMed ID: 9458798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study.
    Kerstjens HAM; Maspero J; Chapman KR; van Zyl-Smit RN; Hosoe M; Tanase AM; Lavecchia C; Pethe A; Shu X; D'Andrea P;
    Lancet Respir Med; 2020 Oct; 8(10):1000-1012. PubMed ID: 32653074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study.
    Wedzicha JA; Zhong N; Ichinose M; Humphries M; Fogel R; Thach C; Patalano F; Banerji D
    Int J Chron Obstruct Pulmon Dis; 2017; 12():339-349. PubMed ID: 28176893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indacaterol/glycopyrronium affects lung function and cardiovascular events in patients with chronic obstructive pulmonary diseases: A meta-analysis.
    Zhang Q; Zhang H; Wang J; Ruan Z; Dai Y; Xia Z; Lv Q
    Heart Lung; 2021; 50(4):532-541. PubMed ID: 33865004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of dual bronchodilators in COPD: A review of the current evidence for indacaterol/glycopyrronium.
    Ficker JH; Rabe KF; Welte T
    Pulm Pharmacol Ther; 2017 Aug; 45():19-33. PubMed ID: 28389258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and safety of indacaterol and glycopyrronium (IND/GLY) following repeated once daily inhalation from a fixed-dose combination in healthy Chinese subjects
.
    Ren S; Sechaud R; Su Z; Tillmann HC; Hara H; Tan X; Hou J; Woessner R; Zhao R
    Int J Clin Pharmacol Ther; 2017 Feb; 55(2):147-155. PubMed ID: 27841152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of a fixed-dose combination of indacaterol and glycopyrronium as maintenance treatment for COPD.
    Chan MC; Tan EC; Yang MC
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1079-1088. PubMed ID: 29670344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of direct switch to indacaterol/glycopyrronium in patients with moderate COPD: the CRYSTAL open-label randomised trial.
    Vogelmeier CF; Gaga M; Aalamian-Mattheis M; Greulich T; Marin JM; Castellani W; Ninane V; Lane S; Nunez X; Patalano F; Clemens A; Kostikas K;
    Respir Res; 2017 Jul; 18(1):140. PubMed ID: 28720132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD: the DuoSleep study.
    Lehmann S; Ringbæk T; Løkke A; Grote L; Hedner J; Lindberg E
    Int J Chron Obstruct Pulmon Dis; 2019; 14():199-210. PubMed ID: 30666100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cromakalim on neurally-mediated responses of guinea-pig tracheal smooth muscle.
    Burka JF; Berry JL; Foster RW; Small RC; Watt AJ
    Br J Pharmacol; 1991 Sep; 104(1):263-9. PubMed ID: 1664764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.